Page 511 - Encyclopedia of Nursing Research
P. 511

478  n  SmOKIng/TOBACCO AS A CARDIOVASCUlAR RISK FACTOR



           2010).  Smoking  is  highest  in  non-hispanic   disease  (lu  &  Creager,  2004).  Smoking
           American  Indians  or  Alaska  natives,  and   adversely affects the following: (1) endothe-
   S       lowest in non-hispanic Asians. The preva-  lial  system,  (2)  lipoprotein  metabolism,  (3)
           lence  of  smoking  varies  considerably  from   blood coagulation, (4) platelets, and (5) oxy-
           state to state and is highest in West Virginia   gen supply and demand (miller, 2008).
           (26.5%)  and  lowest  in  Utah  (9.3%)  (Centers   The  hazardous  effects  of  smoking  are
           for  Disease  Control,  2009).  Smoking  prev-  also  found  for  those  exposed  to  tobacco.
           alence  is  highly  dependent  on  the  success   nonsmokers  exposed  to  environmental
           of  tobacco-related  legislation  and  policies   tobacco smoke suffer an increased 30% risk
           within  states  and  is  often  higher  in  states   of  developing  ischemic  heart  disease.  On
           where tobacco is grown. Although the time   the  basis  of  measurements  of  urinary  coti-
           of  initiation  of  smoking  is  14  to  15  years,   nine,  the  national  Research  Council  (1986)
           the percentage of students ever trying ciga-  estimates that environmental tobacco expo-
           rettes declined from 70.4% in 1999 to 50.3%   sure is equivalent to actively smoking 0.1 to
           in 2007 (American heart Association, 2010).   1.0  cigarettes  per  day.  An  estimated  35,000
           prevention  strategies  within  schools  and   ischemic  heart  disease  deaths  annually  are
           a greater focus on tobacco legislation have   believed to be due to the effects of environ-
           likely led to this decline.              mental  tobacco  exposure  which  includes
              Smoking affects almost every tissue and   both  sidestream  (burning  cigarettes)  and
           organ in the body and is associated with high   mainstream  (smokers’  exhalation)  smoke
           rates  of  common  diseases  such  as  chronic   (glantz & parmley, 1991).
           obstructive  pulmonary  disease,  most  can-  Smoking also imposes a significant social
           cers,  and  cardiovascular  disease.  Smoking   burden  due  to  the  high  costs  of  tobacco-
           is a major risk factor for coronary heart dis-  related  illnesses.  The  health  care  expendi-
           ease,  peripheral  vascular  disease,  aortic   tures associated with smoking are estimated
           aneurysm, and stroke. The relative risks are   at $96 billion in direct medical costs and $97
           greatest  for  those  with  peripheral  vascular   billion in lost productivity (American heart
           disease and lowest for stroke, with interme-  Association, 2010).
           diate  relative  risks  in  those  with  coronary   In 2008, the U.S. Department of health
           heart disease and aortic aneurysm. In addi-  and  human  Services  updated  the  Clinical
           tion, smoking increases the risk of coronary   practice guideline on Treating Tobacco Use
           thrombosis  and  sudden  cardiac  death.  The   and Dependence. published initially in 1996,
           risk  of  coronary  heart  disease,  the  leading   the guideline reviewed over 8,700 studies on
           cause of death in those less than 45, relates   smoking conducted from 1975 to 2007. On the
           to all levels of cigarette smoking, including   basis  of  strong  evidence  from  randomized
           those individuals smoking less than 5 ciga-  controlled trials, this guideline recommends
           rettes per day (Burns, 2003). Finally, smoking   the following: (1) brief interventions of 3 min-
           reduces the life span of males by 13.2 years   utes are recommended for all current smok-
           and of women by 14.5 years (American heart   ers,  those  unwilling  to  make  an  attempt,
           Association, 2010).                      and former smokers who have recently quit;
              Smoking  has  important  adverse  path-  (2)  both  pharmacotherapies  and  behavioral
           ophysiological  effects  on  the  vascular  sys-  counseling work best when combined; (3) the
           tem. most of the toxic effects of smoking are   5 “A’s” of asking about smoking, advising to
           found in the 4,000 compounds in cigarettes.   quit, assessing willingness to quit, assisting
           Although carbon monoxide and nicotine are   those ready to make an attempt, and arrang-
           often thought to be the worst culprits asso-  ing for follow-up continue to be advocated;
           ciated with smoking, toxins cause damage   (4)  medications  should  be  offered  to  every-
           along different pathways leading to vascular   one  except  those  populations  with  lack  of
   506   507   508   509   510   511   512   513   514   515   516